|
Global Autism Partnering 2012-2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Irritable Bowel Syndrome Partnering 2012-2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Dermatology Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
500 |
Global |
$2,995.00 |
|
|
Global Malaria Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Non-Small Cell Lung Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Motor Neurone Disease Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global In Vitro Diagnostics Partnering 2012-2018: Deal trends, players, financials and forecasts |
Sep 1 2018 |
660 |
Global |
$2,995.00 |
|
|
Global Surgery Partnering 2012 to 2018 |
Sep 1 2018 |
200 |
Global |
$1,995.00 |
|
|
Global Ophthalmics Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
500 |
Global |
$2,995.00 |
|
|
Global Muscular Dystrophy Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Bipolar Disorder Partnering 2012-2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Crohn's Disease Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Central Nervous System Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
600 |
Global |
$3,495.00 |
|
|
Global Tropical Disease Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Cancer Symptoms Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Spinal Cord Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Cancer Diagnostics Partnering 2012-2018: Deal trends, players, financials and forecasts |
Sep 1 2018 |
700 |
Global |
$2,995.00 |
|
|
Global Contraception Partnering 2012-2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Blood Substitutes Partnering 2012-2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Obstetrics Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
200 |
Global |
$2,995.00 |
|
|
Global Rheumatoid Arthritis Partnering 2012 to 2018 |
Sep 1 2018 |
200 |
Global |
$1,995.00 |
|
|
Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018 |
Mar 30 2018 |
104 |
Global |
$2,995.00 |
|
|
Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies |
Feb 1 2018 |
106 |
Global |
$2,995.00 |
|
|
Antibacterial Therapeutics - High levels of Pipeline Innovation Focused on the Increasing Unmet Need Associated with Antibiotic Resistance |
Jan 1 2018 |
73 |
Global |
$6,995.00 |
|
|
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis |
Jan 1 2018 |
79 |
Global |
$2,995.00 |
|
|
PharmaPoint: Irritable Bowel Syndrome (IBS) - Global Drug Forecast and Market Analysis to 2026 |
Dec 20 2017 |
185 |
Global |
$10,995.00 |
|
|
PharmaPoint: Glaucoma - Global Drug Forecast and Market Analysis to 2026 |
Dec 20 2017 |
280 |
Global |
$10,995.00 |
|
|
Zeltia Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Galderma Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Tuberculosis Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
